Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (German Research Foundation) (HU 1838/1-1, HU 1838/2-1)
Text and Data Mining valid from 2018-07-20
Received: 28 March 2017
Accepted: 8 June 2018
First Online: 20 July 2018
: J.A.H. and E.K.G. are the named inventors on European Patent Office (EPO) filing 16159985.6-1402 dated 11.03.2016, ‘Immunoregulatory cells and methods for their production’. J.A.H., P.R. and E.K.G. are the named inventors on EPO filing 17206021.2-1111, ‘New drug screening assay using regulatory macrophages’, dated 07.12.2017. The remaining authors declare no competing interests. Trizell GmbH holds commercial rights to clinical application of Mreg_UKR as a therapeutic cell-based product.